Biotechnology company Apriori Bio has been awarded US $1.1 million from CEPI to advance its biology-informed artificial intelligence platform Octavi...
Eli Lilly and Company (NYSE: LLY) and Morphic Holding, Inc. (NASDAQ: MORF) announced a definitive agreement for Lilly to acquire Mor...
Vanza triple granted priority review with Prescription Drug User Fee Act (PDUFA) target action date of January 2, 2025 – - EU Marketing Authorizat...
Kisunla slowed cognitive and functional decline by up to 35% compared to placebo at 18 months in its pivotal Phase 3 study and reduced participants' risk...
Biogen Inc. has completed the acquisition of Human Immunology Biosciences (HI-Bio™), a privately-held clinical-stage biotechnology company foc...
Merck known as MSD outside of the United States and Canada, and Orion Corporation announced that notice has been provided of the mutual exercise of...
Dawn Health, the digital health company pioneering patient-first innovation, has announced they are working with leading global pharmaceutical company, M...
Moderna, announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion ...
Bio-Rad Laboratories, a global leader in life science research and clinical diagnostics products, today announced the launch of Celselect Slides 2....
AbbVie (NYSE: ABBV) announced the acquisition of Celsius Therapeutics, Inc. ("Celsius"), a privately held biotechnology company pioneering new...
The PPD clinical research business will nearly double its laboratory footprint in northern Kentucky, add more than 250 jobs The PPD clinical research bu...
The World Health Organization (WHO) has awarded Roche's human papillomavirus (HPV) test prequalification designations for use on the cobas 5800 System ...
Bio-Rad Laboratories, a global leader in life science research and clinical diagnostics products, today launched four new anti-idiotypic anti...
The status is based on preclinical data and data from an ongoing phase 1/2 study for BNT324/DB-1311; preliminary phase 1/2 clinical data showed anti-tu...
© 2025 Biopharma Boardroom. All Rights Reserved.
